DR LAL PATHLABS
Back to Cashflow Statement
|
DR LAL PATHLABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-334 Cr | ₹-414 Cr | ₹-283 Cr | ₹136 Cr | ₹-139 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR LAL PATHLABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-334 Cr |
| Mar2024 | ₹-414 Cr |
| Mar2023 | ₹-283 Cr |
| Mar2022 | ₹136 Cr |
| Mar2021 | ₹-139 Cr |
How is Cash Flow from Financing Activities of DR LAL PATHLABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-334 Cr | Negative | |
| Mar2024 | ₹-414 Cr | Negative | |
| Mar2023 | ₹-283 Cr | Negative | |
| Mar2022 | ₹136 Cr | Positive | |
| Mar2021 | ₹-139 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹23,801.7 Cr | 1.6% | -5.9% | 6.5% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹99,695.2 Cr | 1.2% | -2.5% | 3.3% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹93,257.3 Cr | 0.1% | -8.6% | -4.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹63,348.5 Cr | -1.2% | -6.6% | 43.3% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹36,046.2 Cr | 0.2% | -8.8% | 42.3% | Stock Analytics | |
| GLOBAL HEALTH | ₹30,646.1 Cr | 8.8% | -4.4% | 10.2% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 1.6% |
-5.9% |
6.5% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses